These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 206138)
21. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone. Fujita T; Nomura M; Okajima S; Furuya H J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136 [TBL] [Abstract][Full Text] [Related]
22. Hyperphosphatemia modestly retards parathyroid hormone suppression during calcitriol-induced hypercalcemia in normal and azotemic rats. Jara A; Chacón C; Felsenfeld AJ Nephron; 2002 Dec; 92(4):883-8. PubMed ID: 12399635 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent. Hirschel-Scholz S; Caverzasio J; Bonjour JP J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292 [TBL] [Abstract][Full Text] [Related]
24. Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy. Ryzen E; Rea TH; Singer FR Am J Med; 1988 Feb; 84(2):325-9. PubMed ID: 2841852 [TBL] [Abstract][Full Text] [Related]
25. Autoregulation in the parathyroid glands by PTH/PTHrP receptor ligands in normal and uremic rats. Lewin E; Garfia B; Almaden Y; Rodriguez M; Olgaard K Kidney Int; 2003 Jul; 64(1):63-70. PubMed ID: 12787396 [TBL] [Abstract][Full Text] [Related]
26. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases. Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061 [TBL] [Abstract][Full Text] [Related]
27. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands. Lewin E; Almaden Y; Rodriguez M; Olgaard K Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551 [TBL] [Abstract][Full Text] [Related]
28. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract. Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700 [TBL] [Abstract][Full Text] [Related]
29. Parathyroid function tests with EDTA infusions in infancy and childhood. Tsang RC; Chen IW; McEnery P; Brown DR; Johnson JR; Lesniewicz J J Pediatr; 1976 Feb; 88(2):250-6. PubMed ID: 175144 [TBL] [Abstract][Full Text] [Related]
30. [Hypercalcemia after the conditioning of allogeneic bone marrow transplantation in a patient with Burkitt's lymphoma]. Fukuda M; Nimura T; Miura I; Mamiya S; Takatsu H; Nakayama Y; Kimura Y; Miura A; Watanuki T Rinsho Ketsueki; 1985 Jun; 26(6):951-6. PubMed ID: 3906175 [No Abstract] [Full Text] [Related]
31. Urinary cyclic 3',5'-adenosine monophosphate (cAMP): an index of the action of parathyroid hormone on the kidney. Marx SJ; Spiegel AM; Brown EM; Downs RW; Attie MF; Stock JL; Levine MA; Aurbach GD Prog Biochem Pharmacol; 1980; 17():182-9. PubMed ID: 6259655 [TBL] [Abstract][Full Text] [Related]
32. Infusions of parathyroid hormone in ruminants: hypercalcemia and reduced plasma 1,25-dihydroxyvitamin D concentrations. Hove K; Horst RL; Littledike ET; Beitz DC Endocrinology; 1984 Mar; 114(3):897-903. PubMed ID: 6546544 [TBL] [Abstract][Full Text] [Related]
33. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445 [TBL] [Abstract][Full Text] [Related]
34. Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer. Kukreja SC; Shemerdiak WP; Lad TE; Johnson PA J Clin Endocrinol Metab; 1980 Jul; 51(1):167-9. PubMed ID: 6247360 [TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone-independent hypercalcemia in an infant with renal dysplasia: possible role of PTHrP. Grob F; Zambrano P; Ibarra X; Reyes ML J Pediatr Endocrinol Metab; 2013; 26(3-4):365-7. PubMed ID: 23327815 [TBL] [Abstract][Full Text] [Related]
36. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma. Warrell RP; Issacs M; Alcock NW; Bockman RS Ann Intern Med; 1987 Nov; 107(5):683-6. PubMed ID: 2821862 [TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia with nephrocalcinosis and impaired renal function due to increased Parathyroid hormone secretion at onset of childhood acute lymphoblastic leukemia. Lankisch P; Kramm CM; Hermsen D; Wessalowski R Leuk Lymphoma; 2004 Aug; 45(8):1695-7. PubMed ID: 15370228 [TBL] [Abstract][Full Text] [Related]
38. Effect of Ca++ on renal handling of PO4 identical to: evidence for two reabsorptive mechanisms. Popovtzer MM; Robinette JB; McDonald KM; Kuruvila CK Am J Physiol; 1975 Oct; 229(4):901-6. PubMed ID: 171963 [TBL] [Abstract][Full Text] [Related]
39. Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy. Godsall JW; Burtis WJ; Insogna KL; Broadus AE; Stewart AF Recent Prog Horm Res; 1986; 42():705-50. PubMed ID: 3016837 [No Abstract] [Full Text] [Related]